Urogen Pharma INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersPrinceton, NJ
SAM.gov UEIL3U3BFJL3Z81
UroGen Pharma develops pharmaceutical treatments for urological cancers using its RTGel technology platform. The company's FDA-approved medicines include Zusduri (mitomycin) for intravesical solution and Jelmyto (mitomycin) for pyelocalyceal solution, and it maintains a pipeline of treatments focused on uro-oncology patients.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Urogen Pharma INC | Princeton | NJ | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.